Medication info
Danaril Tablet (Glymepiride)

Danaril Tablet (Glymepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Daewon Biotech Co., Ltd.
Appearance
Green, oblong tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202000688 · Approved 2020.02.06 · Insurance code 057600570

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 glass of water. This product is administered orally once daily. Take this product before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this product. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If needed, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have shown better metabolic control with dose increases up to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this product may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral hypoglycemic agent to this product There is no exact dose equivalence between this product and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this product, follow the method described under Initial dose. That is, start treatment with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previously administered medication. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this product with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this product once daily with the first meal. Start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Periodically adjust the insulin dose while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this product, addition of metformin may be considered. In combination therapy with this product and metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control.

Ingredients

Manufacturer
Daewon Biotech Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Abnormal blood glucose control in patients with type 2 diabetes
View approved original text

This medication is used along with dietary and exercise therapy to assist in the control of blood glucose levels in patients with type 2 diabetes. It can be administered as monotherapy, and in cases where blood glucose control is difficult, it may be used in combination with other oral hypoglycemic agents or insulin. It improves blood glucose management when administered with metformin in patients who do not achieve adequate control with sulfonylureas or metformin. This medication effectively assists in blood glucose control and is used for the management of diabetes.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 glass of water. This product is administered orally once daily. Take this product before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this product. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If needed, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have shown better metabolic control with dose increases up to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this product may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral hypoglycemic agent to this product There is no exact dose equivalence between this product and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this product, follow the method described under Initial dose. That is, start treatment with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previously administered medication. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this product with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this product once daily with the first meal. Start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Periodically adjust the insulin dose while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this product, addition of metformin may be considered. In combination therapy with this product and metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or in coma. It should also be avoided in individuals with allergies to any ingredient included in this medication or similar medications. Patients with severely impaired liver or kidney function should not use this medication, and it is recommended to switch to insulin therapy in such cases. Women who are pregnant or may become pregnant and those who are breastfeeding should not take this medication. Patients with severe infections, undergoing surgery, or with severe trauma should use insulin therapy instead of this medication. When gastrointestinal disturbances such as diarrhea or vomiting occur, there is a risk of hypoglycemia due to poor absorption of food; hence caution should be exercised. Patients with genetic conditions like lactose intolerance, lactase deficiency, or glucose-galactose malabsorption should not take this medication. The risk of hypoglycemia is high during the initial week of treatment, so blood glucose should be checked frequently and monitored closely. Elderly individuals, malnourished patients, those skipping meals, patients consuming large amounts of alcohol, and those with compromised liver or kidney function are at higher risk for hypoglycemia. When taking with other medications, consultation with a doctor or pharmacist is necessary, as interactions may impact blood glucose control. In case of hypoglycemic symptoms, immediately ingest food containing sugar to alleviate symptoms; in severe cases, seek medical assistance. Serious side effects such as liver function anomalies, blood disorders, and allergic reactions may occur; report any unusual symptoms to a doctor immediately. During treatment with this medication, maintaining a regular diet, exercise, and weight control is crucial, as is undergoing regular blood glucose and urine sugar tests. Pregnant or breastfeeding women should not take this medication and should switch to insulin therapy if necessary. In case of overdose, severe hypoglycemia may occur, requiring immediate hospitalization and treatment, such as inducing vomiting, administering activated charcoal, or glucose injection. This medication is not recommended for children as its safety and efficacy have not been established in pediatric populations.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, cerebral convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, hives, rash, difficulty breathing, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergy vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Also, to maintain its effectiveness, it is best to store it at a temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Green, oblong tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.